Blood substitute offers lifeline for patients who Can't get transfusions
NCT ID NCT02684474
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 31 times
Summary
This study provided an experimental blood substitute called HBOC-201 to adults with life-threatening anemia who could not receive standard blood transfusions. The treatment is made from purified cow hemoglobin and helps carry oxygen to tissues without needing blood type matching. It was offered to critically ill patients with very low hemoglobin levels and signs of organ damage from lack of oxygen.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Johns Hopkins Hospital
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.